Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease

 		Coronary Heart Disease Phase2 United States
Canada

Ribociclib (LEE011) Rollover Study for Continued Access

 		Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies Phase2 Taiwan
United States

Kesimpta (Ofatumumab) Pregnancy Registry

 		Multiple Sclerosis, Pregnancy United States

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

 		Systemic Lupus Erythematosus Phase3 Spain

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

 		Melanoma China

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

 		Metastatic Uveal Melanoma Phase1, Phase2 United States
Germany
Netherlands
Spain
Australia
France
Switzerland
View All

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

 		Relapsing Multiple Sclerosis Germany

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

 		Warm Autoimmune Hemolytic Anemia (wAIHA) Phase3 United States
Israel
Japan
Italy
Thailand
Spain
France
Romania
Argentina
Australia
China
Hungary
Germany
Malaysia
United Kingdom
India
Singapore
Taiwan
View All

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

 		Prostate Cancer Phase2 Japan

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

 		Non-small Cell Lung Cancer Phase1 United States
Spain
Japan
Germany
Switzerland
Korea, Republic of
View All